Delivery Order SPE2DB22D2005-SPE2DB25FJSK9
- Not listed
- The Defense Logistics Agency awarded a $2,707.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-HC Ear Suspension (10mL) on July 23, 2025, with completion expected by July 24, 2025. This award is a non-competitive delivery order issued under an existing contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The pharmaceutical product supplied under this delivery order serves medical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,421.24 for Neomycin-Polymyxin-HC Ear Suspension 10ML on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The IDC, valued at $999.99 million and extending through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,717.50 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Neomycin-Polymyxin-HC Ear Suspension in 10mL units. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Corporate Office division. The award...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,735.11 on August 11, 2025, for the supply of Neomycin-Polymyxin-HC Ear Suspension (10mL) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The contract, which is not set-aside, has an ultimate completion date of August 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,032.18 by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the supply of Neomycin-Polymyxin-HC ear solution in 10 milliliter quantities. The award is structured as a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.52 to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension (7.5mL) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order for pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order valued at $1,532.22 to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-Gramicidin eye drops (10mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support military and federal healthcare systems'...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,356.62 delivery order on September 3, 2025, for the supply of Neomycin-Poly-HC eye drops in 7.5ml quantities. This firm fixed price, non-set-aside contract is expected to be completed by September 4, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.78 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,574.71 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSK9Delivery Order
The Defense Logistics Agency awarded a $2,038.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-HC ear suspension (10mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive $999.9 billion prime IDC with DLA Troop Support Medical, which extends through December 2026 and functions as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The competitively awarded IDC reflects the contractor's capability to fulfill federal medical procurement requirements and supports the DLA's strategic pharmaceutical supply chain operations serving military personnel and veterans worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/22/25 |